environment.uq.edu.au
Feb 23, 2026, 17:42
Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
Bryan Fry, Professor of Toxicology at the University of Queensland, shared a post on LinkedIn, about a recent article he and his colleagues co-authored, adding:
”Highlights
- Neonate Bothrops atrox venom is far more procoagulant than adult venom on plasma and fibrinogen.
- Neonate venom activates prothrombin and Factor VII via FVa-dependent pathways more strongly than adults.
- We provide the first evidence that Bothrops atrox venom directly activates human Factor VII.
- Clinically used antivenoms neutralise adult venom better than neonate venom; Butantan performs best.
- Findings indicate high coagulopathy risk after neonate bites and support adding neonate venom to antivenom immunizing mixture.”
Title: Pirates of the coagulase: Clinical implications of dramatic ontogenetic shifts in Yellow Beard (Bothrops atrox) lancehead pitviper Factor Va-mediated venom activation of blood clotting factors
Authors: Katherine Jordan, Patrick S. Champagne, Lorenzo Seneci, Bryan G. Fry
Read the Full Article on Toxicon.
Stay updated with Hemostasis Today.
-
Apr 12, 2026, 22:12Maciej Banach: The ‘Metastatic’ Cardiovascular Threat We Can No Longer Ignore
-
Apr 12, 2026, 21:52Umar Jawed: The Most Dangerous Anti-D Result Is Not the Highest One – It’s the One You Underestimate Early
-
Apr 12, 2026, 21:37Demosthenes Panagiotakos: Hellenic Atherosclerosis Society Calls for Papers on Innovative Strategies in Atherosclerotic Plaque Management
-
Apr 12, 2026, 21:24Heghine Khachatryan: Diagnosing PNH in Resource-Limited Settings
-
Apr 12, 2026, 21:15Katariina Öörni: Role of Cholesterol Absorption Efficiency in Atherosclerosis
-
Apr 12, 2026, 17:34Caitlin Raymond: Granulocyte Transfusions for the Overworked Fellow
-
Apr 12, 2026, 17:33Augustina Isioma Ikusemoro: ABO Typing Is Not the Same in Infants and Adults
-
Apr 12, 2026, 17:32Bastu Odoka: Same Blood Group Does Not Guarantee Compatibility
-
Apr 12, 2026, 17:31Jack Hadfield: SARS-CoV-2–Associated Lasting Mitochondrial Injury in Cardiomyocytes